DENTSU GROUP INC. Logo

DENTSU GROUP INC.

Global advertising & marketing firm integrating tech and consulting for brand growth.

4324 | T

Overview

Corporate Details

ISIN(s):
JP3551520004
LEI:
Country:
Japan
Address:
港区東新橋一丁目8番1号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Dentsu Group Inc. is a multinational advertising and marketing services company that provides integrated growth solutions. The company's core strategy is based on the convergence of marketing, technology, and consulting to deliver unique solutions for its clients. Its comprehensive service portfolio includes advertising across all media, communications strategy, digital creative execution, media planning and buying, sports marketing, and content creation. Operating a global network across approximately 120 countries, Dentsu leverages its diverse capabilities to help brands address complex business challenges, drive innovation, and achieve sustainable growth.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 09:18
Registration Form
訂正発行登録書
Japanese 10.0 KB
2025-08-14 09:07
Report Publication Announcement
確認書
Japanese 8.9 KB
2025-08-14 09:05
Interim Report
半期報告書-第177期(2025/01/01-2025/12/31)
Japanese 382.7 KB
2025-08-08 08:09
Registration Form
訂正発行登録書
Japanese 9.8 KB
2025-08-08 07:09
Regulatory News Service
確認書
Japanese 8.9 KB
2025-08-08 07:04
Regulatory News Service
訂正有価証券報告書-第176期(2024/01/01-2024/12/31)
Japanese 1.4 MB
2025-07-30 03:14
Major Shareholding Notification
大量保有報告書
Japanese 38.4 KB
2025-06-27 07:59
Major Shareholding Notification
変更報告書
Japanese 42.3 KB
2025-05-23 03:04
Major Shareholding Notification
訂正報告書(大量保有報告書・変更報告書)
Japanese 36.6 KB
2025-05-22 03:48
Major Shareholding Notification
変更報告書
Japanese 38.2 KB
2025-05-09 08:00
Registration Form
発行登録書(株券、社債券等)
Japanese 28.5 KB
2025-04-01 04:03
Post-Annual General Meeting Information
臨時報告書
Japanese 26.3 KB
2025-03-28 06:16
Registration Form
確認書
Japanese 8.9 KB
2025-03-28 06:13
Governance Information
内部統制報告書-第176期(2024/01/01-2024/12/31)
Japanese 23.7 KB
2025-03-28 06:10
Annual Report
有価証券報告書-第176期(2024/01/01-2024/12/31)
Japanese 2.5 MB

Automate Your Workflow. Get a real-time feed of all DENTSU GROUP INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DENTSU GROUP INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for DENTSU GROUP INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Advancing high-grade copper and precious metal projects from discovery to production.
Canada
COR
Cantargia Logo
Develops antibody treatments targeting IL1RAP for cancer and autoimmune/inflammatory diseases.
Sweden
CANTA
Captor Therapeutics S.A. Logo
Developing TPD therapeutics for oncology and autoimmune diseases with its Optigrade™ platform.
Poland
CTX
Cardiff Oncology, Inc. Logo
Clinical-stage biotech developing a PLK1 inhibitor to treat resistant cancers.
United States of America
CRDF
Cardio Diagnostics Holdings, Inc. Logo
AI-powered epigenetic and genetic tests for early detection of heart disease risk.
United States of America
CDIO
Cardiol Therapeutics Inc. Logo
Develops oral cannabidiol therapies for inflammatory and fibrotic heart diseases.
United States of America
CRDL
CareDx, Inc. Logo
Precision diagnostics and surveillance solutions for the organ transplant journey.
United States of America
CDNA
Offers one-stop BPO, CRM, and staffing for admin, manufacturing, and logistics.
Japan
6070
Caris Life Sciences, Inc. Logo
Pioneering precision cancer care via AI-powered molecular profiling and diagnostics.
United States of America
CAI
Carna Biosciences, Inc. Logo
Develops kinase inhibitor drugs for oncology/autoimmune diseases & offers discovery support services.
Japan
4572

Talk to a Data Expert

Have a question? We'll get back to you promptly.